Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Br J Haematol
    September 2021
  1. BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
    COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
    Br J Haematol. 2021;194:854-856.
    >> Share

  2. MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
    Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
    Br J Haematol. 2021;194:851-854.
    >> Share

    July 2021
  3. FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
    Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
    Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.
    >> Share

    June 2021
  4. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.
    >> Share

  5. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.
    >> Share

    April 2021
  6. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    >> Share

  7. BENNETT R, Ruskova A
    Atezolizumab-induced pure red cell aplasia.
    Br J Haematol. 2021;193:10.
    >> Share

  8. LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
    The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
    Br J Haematol. 2021;193:26-42.
    >> Share

    March 2021
  9. SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
    Cognitive performance as a predictor of healthcare transition in sickle cell disease.
    Br J Haematol. 2021;192:1082-1091.
    >> Share

  10. AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol. 2021;192:1092-1096.
    >> Share

  11. EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
    Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Br J Haematol. 2021;192:909-921.
    >> Share

  12. ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
    Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Br J Haematol. 2021;192:e129-e132.
    >> Share

  13. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.
    >> Share

  14. SACHDEV V, Tian X, Gu Y, Nichols J, et al
    A phenotypic risk score for predicting mortality in sickle cell disease.
    Br J Haematol. 2021;192:932-941.
    >> Share

  15. RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
    Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Br J Haematol. 2021;192:922-931.
    >> Share

    February 2021
  16. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.
    >> Share

  17. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.
    >> Share

  18. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    >> Share

  19. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    >> Share

  20. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    >> Share

  21. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.
    >> Share

  22. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    >> Share

  23. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    >> Share

  24. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    >> Share

    January 2021
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.
    >> Share

  26. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    >> Share

  27. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.
    >> Share

  28. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.
    >> Share

  29. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    >> Share

  30. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    >> Share

  31. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    >> Share

  32. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    >> Share

  33. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.
    >> Share

  34. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    >> Share

  35. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    >> Share

    December 2020
  36. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.
    >> Share

  37. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    >> Share

  38. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    >> Share

  39. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.
    >> Share

  40. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    >> Share

  41. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    >> Share

  42. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    >> Share

    November 2020
  43. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    >> Share

  44. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.
    >> Share

  45. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.
    >> Share

  46. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.
    >> Share

  47. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.
    >> Share

  48. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    >> Share

  49. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    >> Share

    October 2020
  50. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
    >> Share

  51. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.
    >> Share

  52. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.
    >> Share

  53. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.
    >> Share

  54. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.
    >> Share

  55. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    >> Share

  56. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    >> Share

    September 2020
  57. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.
    >> Share

    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.
    >> Share

  59. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.
    >> Share

  60. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.
    >> Share

  61. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.
    >> Share

  62. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.
    >> Share

  63. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.
    >> Share

  64. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    >> Share

    August 2020
  65. KULASEKARARAJ AG, Lazana I, Large J, Posadas K, et al
    Terminal complement inhibition dampens the inflammation during COVID-19.
    Br J Haematol. 2020;190:e141-e143.
    >> Share

  66. KARIMI M, Haghpanah S, Azarkeivan A, Zahedi Z, et al
    Prevalence and mortality in beta-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.
    Br J Haematol. 2020;190:e137-e140.
    >> Share

  67. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.
    >> Share

    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.
    >> Share

    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.
    >> Share

  70. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.
    >> Share

    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.
    >> Share

  72. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.
    >> Share

  73. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.
    >> Share

  74. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.
    >> Share

  75. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.
    >> Share

  76. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.
    >> Share

  77. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    >> Share

  78. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    >> Share

  79. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    >> Share

  80. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    >> Share

  81. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    >> Share

    July 2020
  82. HEILBRONNER C, Berteloot L, Tremolieres P, Dupic L, et al
    Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.
    Br J Haematol. 2020;190:e21-e24.
    >> Share

  83. SAHU KK, Siddiqui AD, Cerny J
    Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.
    Br J Haematol. 2020;190:e86-e89.
    >> Share

  84. LI M, Nguyen CB, Yeung Z, Sanchez K, et al
    Evans syndrome in a patient with COVID-19.
    Br J Haematol. 2020;190:e59-e61.
    >> Share

  85. MCCLOSKEY KA, Meenan J, Hall R, Tsitsikas DA, et al
    COVID-19 infection and sickle cell disease: a UK centre experience.
    Br J Haematol. 2020;190:e57-e58.
    >> Share

    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.
    >> Share

  87. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.
    >> Share

  88. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    >> Share

  89. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    >> Share

    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.
    >> Share

  91. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    >> Share

  92. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    >> Share

    June 2020
  93. HUSSAIN FA, Njoku FU, Saraf SL, Molokie RE, et al
    COVID-19 infection in patients with sickle cell disease.
    Br J Haematol. 2020;189:851-852.
    >> Share

    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.
    >> Share

  95. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.
    >> Share

  96. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.
    >> Share

  97. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.
    >> Share

  98. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.
    >> Share

  99. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    >> Share

  100. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    >> Share

  101. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.
    >> Share

  102. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    >> Share

  103. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    >> Share

  104. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    >> Share

    May 2020
  105. ZAGORSKI E, Pawar T, Rahimian S, Forman D, et al
    Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).
    Br J Haematol. 2020 May 27. doi: 10.1111/bjh.16892.
    >> Share

  106. ANGILERI F, Legare S, Marino Gammazza A, Conway de Macario E, et al
    Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?
    Br J Haematol. 2020 May 26. doi: 10.1111/bjh.16883.
    >> Share

  107. LAZARIAN G, Quinquenel A, Bellal M, Siavellis J, et al
    Autoimmune hemolytic anemia associated with Covid-19 infection.
    Br J Haematol. 2020 May 6. doi: 10.1111/bjh.16794.
    >> Share

  108. LOPEZ C, Kim J, Pandey A, Huang T, et al
    Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.
    Br J Haematol. 2020 May 5. doi: 10.1111/bjh.16786.
    >> Share

  109. ROY NBA, Telfer P, Eleftheriou P, de la Fuente J, et al
    Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.
    Br J Haematol. 2020;189:635-639.
    >> Share

  110. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.
    >> Share

  111. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.
    >> Share

  112. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.
    >> Share

  113. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.
    >> Share

  114. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    >> Share

  115. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    >> Share

  116. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    >> Share

    April 2020
  117. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.
    >> Share

  118. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.
    >> Share

  119. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.
    >> Share

  120. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    >> Share

  121. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    >> Share

  122. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    >> Share

  123. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.
    >> Share

    March 2020
  124. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.
    >> Share

  125. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    >> Share

  126. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    >> Share

  127. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.
    >> Share

  128. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    >> Share

  129. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.
    >> Share

    February 2020
  130. NZE C, Fortin B, Freedman R, Mandell E, et al
    Sudden death in sickle cell disease: current experience.
    Br J Haematol. 2020;188:e43-e45.
    >> Share

  131. SANCHEZ-PETITTO G, Drachenberg CB, Mannuel HD, Law JY, et al
    An unusual presentation of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2020;188:347.
    >> Share

  132. SHAH S, Sheth R, Shah K, Patel K, et al
    Safety and effectiveness of thalidomide and hydroxyurea combination in beta-thalassaemia intermedia and major: a retrospective pilot study.
    Br J Haematol. 2020;188:e18-e21.
    >> Share

  133. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients.
    Br J Haematol. 2020;188:e8-e11.
    >> Share

  134. DUTTA D, Aujla A, Knoll BM, Lim SH, et al
    Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.
    Br J Haematol. 2020;188:488-493.
    >> Share

  135. SAITO-BENZ M, Flanagan P, Berry MJ
    Management of anaemia in pre-term infants.
    Br J Haematol. 2020;188:354-366.
    >> Share

    January 2020
  136. SCHOLS S, Nunn MA, Mackie I, Weston-Davies W, et al
    Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
    Br J Haematol. 2020;188:334-337.
    >> Share

  137. WANG Y, McReynolds LJ, Dagnall C, Katki HA, et al
    Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.
    Br J Haematol. 2020;188:309-316.
    >> Share

    April 2019
  138. SCHOLZ GA, Leichtle AB, Scherer A, Arndt U, et al
    The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis.
    Br J Haematol. 2019 Apr 2. doi: 10.1111/bjh.15895.
    >> Share

  139. RUND D
    Bittersweet news for the adult sickle cell patient.
    Br J Haematol. 2019;185:9-10.
    >> Share

  140. ZHOU J, Han J, Nutescu EA, Galanter WL, et al
    Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
    Br J Haematol. 2019;185:116-127.
    >> Share

  141. NASHASHIBI J, Avraham GR, Schwartz N, Awni Y, et al
    Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study.
    Br J Haematol. 2019;185:93-101.
    >> Share

  142. BELISARIO AR, Vieira ELM, de Almeida JA, Mendes FG, et al
    Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia.
    Br J Haematol. 2019;185:190-193.
    >> Share

  143. MORISSENS M, Castro Rodriguez J, Azerad MA, Besse-Hammer T, et al
    Added value of speckle tracking in the evaluation of cardiac function in patients with sickle cell disease.
    Br J Haematol. 2019;185:151-153.
    >> Share

  144. BRUNSON A, Keegan THM, Mahajan A, Paulukonis S, et al
    Cancer specific survival in patients with sickle cell disease.
    Br J Haematol. 2019;185:128-132.
    >> Share

  145. DAY ME, Rodeghier M, Driggers J, Bean CJ, et al
    A significant proportion of children of African descent with HbSbeta(0) thalassaemia are inaccurately diagnosed based on phenotypic analyses alone.
    Br J Haematol. 2019;185:153-156.
    >> Share

    March 2019
  146. GRACE RF, Mark Layton D, Barcellini W
    How we manage patients with pyruvate kinase deficiency.
    Br J Haematol. 2019;184:721-734.
    >> Share

  147. WHITE J, Lindgren M, Liu K, Gao X, et al
    Sevuparin blocks sickle blood cell adhesion and sickle-leucocyte rolling on immobilized L-selectin in a dose dependent manner.
    Br J Haematol. 2019;184:873-876.
    >> Share

  148. PELLEGRIN S, Haydn-Smith KL, Hampton-O'Neil LA, Hawley BR, et al
    Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII.
    Br J Haematol. 2019;184:876-881.
    >> Share

  149. ALTER BP, Giri N
    Serum alpha fetoprotein levels in Fanconi anaemia.
    Br J Haematol. 2019;184:1074-1076.
    >> Share

  150. BERGER G, van den Berg E, Smetsers S, Leegte BK, et al
    Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations.
    Br J Haematol. 2019;184:1071-1073.
    >> Share

  151. JIANG H, Zhang H, Wang Y, Qi W, et al
    Sirolimus for the treatment of multi-resistant pure red cell aplasia.
    Br J Haematol. 2019;184:1055-1058.
    >> Share

  152. SALEM B, Mitchell R, DeFor TE, Tryon R, et al
    Elevations in serum alpha fetoprotein levels in patients with Fanconi anaemia.
    Br J Haematol. 2019;184:1032-1035.
    >> Share

  153. KANTER J, Heath LE, Knorr J, Agbenyega ET, et al
    Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia.
    Br J Haematol. 2019;184:1058-1061.
    >> Share

    February 2019
  154. MCGOWAN KE, Malinowski AK, Schuh AC, Whittle W, et al
    Aplastic anaemia in pregnancy - a single centre, North American series.
    Br J Haematol. 2019;184:436-439.
    >> Share

  155. LUZZATTO L, Notaro R
    The "escape" model: a versatile mechanism for clonal expansion.
    Br J Haematol. 2019;184:465-466.
    >> Share

  156. RAVERA S, Degan P, Sabatini F, Columbaro M, et al
    Altered lipid metabolism could drive the bone marrow failure in fanconi anaemia.
    Br J Haematol. 2019;184:693-696.
    >> Share

  157. DARBARI DS, Liljencrantz J, Ikechi A, Martin S, et al
    Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.
    Br J Haematol. 2019;184:690-693.
    >> Share

  158. MARKUS C, Saxon B, Metz M
    Ferritin as a functional biomarker of iron status in children and young adults.
    Br J Haematol. 2019;184:640-642.
    >> Share

  159. MALINOWSKI AK, Cheung P, Yang J, D'Souza R, et al
    Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study.
    Br J Haematol. 2019;184:653-657.
    >> Share

  160. MAJUMDAR S, Tirona R, Mashegu H, Desai J, et al
    A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis.
    Br J Haematol. 2019;184:634-636.
    >> Share

    January 2019
  161. BARTELS M, Bierings M
    How I manage children with Diamond-Blackfan anaemia.
    Br J Haematol. 2019;184:123-133.
    >> Share

  162. ALEXANDRE-HEYMANN L, Dubert M, Diallo DA, Diop S, et al
    Prevalence and correlates of growth failure in young African patients with sickle cell disease.
    Br J Haematol. 2019;184:253-262.
    >> Share

  163. THROWER A, Ciccone EJ, Maitra P, Derebail VK, et al
    Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.
    Br J Haematol. 2019;184:246-252.
    >> Share

  164. KANTER J, Abboud MR, Kaya B, Nduba V, et al
    Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study.
    Br J Haematol. 2019;184:269-278.
    >> Share

  165. SHAH A, Wray K, James T, Shine B, et al
    Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge.
    Br J Haematol. 2019;184:279-281.
    >> Share

    December 2018
  166. NAKAYAMA S, Taniguchi T, Tanaka H, Espinoza JL, et al
    Interleukin-17-producing angioimmunoblastic T-cell lymphoma with Evans syndrome.
    Br J Haematol. 2018 Dec 28. doi: 10.1111/bjh.15733.
    >> Share

  167. PARK S, Greenberg P, Yucel A, Farmer C, et al
    Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review.
    Br J Haematol. 2018 Dec 13. doi: 10.1111/bjh.15707.
    >> Share

    November 2018
  168. YANAMANDRA U, Senee H, Yanamadra S, Das SK, et al
    Erythropoietin and ferritin response in native highlanders aged 4-19 years from the Leh-Ladakh region of India.
    Br J Haematol. 2018 Nov 26. doi: 10.1111/bjh.15553.
    >> Share

    June 2018
  169. HAN J, Zhang X, Saraf SL, Gowhari M, et al
    Risk factors for vitamin D deficiency in sickle cell disease.
    Br J Haematol. 2018;181:828-835.
    >> Share

  170. GUEDENEY P, Lionnet F, Ceccaldi A, Stankovic Stojanovic K, et al
    Cardiac manifestations in sickle cell disease varies with patient genotype.
    Br J Haematol. 2018;181:664-671.
    >> Share

  171. KARAFIN MS, Westlake M, Hauser RG, Tormey CA, et al
    Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Br J Haematol. 2018;181:672-681.
    >> Share

    May 2018
  172. QURESHI A, Kaya B, Pancham S, Keenan R, et al
    Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.
    Br J Haematol. 2018;181:460-475.
    >> Share

  173. SAULTIER P, Loosveld M, Benoist JF, Michel G, et al
    Pancytopenia and megaloblastic erythropoiesis reveal a novel GIF mutation.
    Br J Haematol. 2018;181:304.
    >> Share

    How I manage patients with cold agglutinin disease.
    Br J Haematol. 2018;181:320-330.
    >> Share

  175. JONASSAINT CR, Birenboim A, Jorgensen DR, Novelli EM, et al
    The association of smartphone-based activity space measures with cognitive functioning and pain sickle cell disease.
    Br J Haematol. 2018;181:395-397.
    >> Share

  176. DAGUR PK, McCoy JP, Nichols J, Mendelsohn L, et al
    Haem augments and iron chelation decreases toll-like receptor 4 mediated inflammation in monocytes from sickle cell patients.
    Br J Haematol. 2018;181:552-554.
    >> Share

    April 2018
  177. ZAHR RS, Chappa P, Yin H, Brown LA, et al
    Renal protection by atorvastatin in a murine model of sickle cell nephropathy.
    Br J Haematol. 2018;181:111-121.
    >> Share

  178. RANKINE-MULLINGS AE, Morrison-Levy N, Soares D, Aldred K, et al
    Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition.
    Br J Haematol. 2018;181:242-251.
    >> Share

  179. SOUSOS N, Sinakos E, Klonizakis P, Adamidou D, et al
    Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre.
    Br J Haematol. 2018;181:140-142.
    >> Share

    March 2018
  180. VOGEL S, Thein SL
    Platelets at the crossroads of thrombosis, inflammation and haemolysis.
    Br J Haematol. 2018;180:761-767.
    >> Share

  181. RICCHI P, Meloni A, Spasiano A, Costantini S, et al
    The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
    Br J Haematol. 2018;180:721-726.
    >> Share

  182. JIANG Z, Luo HY, Farrell JJ, Zhang Z, et al
    A variant Sp1 (R218Q) transcription factor might enhance HbF expression in beta(0) -thalassaemia homozygotes.
    Br J Haematol. 2018;180:755-757.
    >> Share

  183. PEPE A, Gamberini MR, Missere M, Pistoia L, et al
    Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up.
    Br J Haematol. 2018;180:879-888.
    >> Share

  184. KERAGALA CB, Draxler DF, McQuilten ZK, Medcalf RL, et al
    Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.
    Br J Haematol. 2018;180:782-798.
    >> Share

    February 2018
  185. TJON JM, de Groot MR, Sypkens Smit SMA, de Wreede LC, et al
    Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
    Br J Haematol. 2018;180:459-462.
    >> Share

  186. REES DC, Robinson S, Howard J
    How I manage red cell transfusions in patients with sickle cell disease.
    Br J Haematol. 2018;180:607-617.
    >> Share

  187. WILLEN SM, Rodeghier M, Strunk RC, Bacharier LB, et al
    Aeroallergen sensitization predicts acute chest syndrome in children with sickle cell anaemia.
    Br J Haematol. 2018;180:571-577.
    >> Share

  188. EKONG A, Berg L, Amos RJ, Tsitsikas DA, et al
    Regular automated red cell exchange transfusion in the management of stuttering priapism complicating sickle cell disease.
    Br J Haematol. 2018;180:585-588.
    >> Share

  189. VACLAVU L, Baldew ZAV, Gevers S, Mutsaerts HJMM, et al
    Intracranial 4D flow magnetic resonance imaging reveals altered haemodynamics in sickle cell disease.
    Br J Haematol. 2018;180:432-442.
    >> Share

    January 2018
  190. SAMARASINGHE S, Veys P, Vora A, Wynn R, et al
    Paediatric amendment to adult BSH Guidelines for aplastic anaemia.
    Br J Haematol. 2018;180:201-205.
    >> Share

  191. WONKAM A, Mnika K, Ngo Bitoungui VJ, Chetcha Chemegni B, et al
    Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.
    Br J Haematol. 2018;180:134-146.
    >> Share

  192. PAIKARI A, Sheehan VA
    Fetal haemoglobin induction in sickle cell disease.
    Br J Haematol. 2018;180:189-200.
    >> Share

  193. CREASEY T, Biss T, Lambert J, Smith F, et al
    Pyridoxine-sensitive X-linked 'sideroblastic' anaemia in the absence of ring sideroblasts - molecular diagnosis.
    Br J Haematol. 2018;180:10.
    >> Share

  194. BIERINGS M, Bonfim C, Peffault De Latour R, Aljurf M, et al
    Transplant results in adults with Fanconi anaemia.
    Br J Haematol. 2018;180:100-109.
    >> Share

  195. CLARK B, Shooter C, Smith F, Brawand D, et al
    Beta thalassaemia intermedia due to co-inheritance of three unique alpha globin cluster duplications characterised by next generation sequencing analysis.
    Br J Haematol. 2018;180:160-164.
    >> Share

    December 2017
  196. ROVO A, Kulasekararaj A, Medinger M, Chevallier P, et al
    Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.
    Br J Haematol. 2017 Dec 19. doi: 10.1111/bjh.15074.
    >> Share

  197. NAIR M, Churchill D, Robinson S, Nelson-Piercy C, et al
    Association between maternal haemoglobin and stillbirth: a cohort study among a multi-ethnic population in England.
    Br J Haematol. 2017;179:829-837.
    >> Share

  198. HAYMANN JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, et al
    Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.
    Br J Haematol. 2017;179:820-828.
    >> Share

    November 2017
  199. FRAME IJ, Coberly J, Fuda FS, Chen M, et al
    Erythrophagocytosis by T-cell lymphoma cells in a patient with hereditary spherocytosis post-splenectomy.
    Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15028.
    >> Share

  200. BREWIN J, Kaya B, Chakravorty S
    How I manage sickle cell patients with high transcranial doppler results.
    Br J Haematol. 2017;179:377-388.
    >> Share

  201. ZAPPIA KJ, Guo Y, Retherford D, Wandersee NJ, et al
    Characterization of a mouse model of sickle cell trait: parallels to human trait and a novel finding of cutaneous sensitization.
    Br J Haematol. 2017;179:657-666.
    >> Share

  202. WINCHENNE A, Cecchini J, Deux JF, De Prost N, et al
    A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.
    Br J Haematol. 2017;179:627-634.
    >> Share

  203. SACHDEV V, Sidenko S, Wu MD, Minniti CP, et al
    Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.
    Br J Haematol. 2017;179:648-656.
    >> Share

  204. MICHELOZZI IM, Pievani A, Pagni F, Antolini L, et al
    Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo.
    Br J Haematol. 2017;179:669-673.
    >> Share

    October 2017
  205. CABANAS-PEDRO AC, Roizenblatt S, de Souza AAL, Tufik S, et al
    Periodic limb movement in sleep and sickle cell disease: a neglected association?
    Br J Haematol. 2017;179:154-157.
    >> Share

  206. VASSEUR C, Domingues-Hamdi E, Ledudal K, Le Corvoisier P, et al
    Red blood cells free alpha-haemoglobin pool: a biomarker to monitor the beta-thalassemia intermedia variability. The ALPHAPOOL study.
    Br J Haematol. 2017;179:142-153.
    >> Share

  207. AL BALUSHI HWM, Wali Y, Al Awadi M, Al-Subhi T, et al
    The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K+ permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype).
    Br J Haematol. 2017;179:256-265.
    >> Share

  208. KORMANN R, Jannot AS, Narjoz C, Ribeil JA, et al
    Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
    Br J Haematol. 2017;179:323-335.
    >> Share

    September 2017
  209. DI MAGGIO R, Maggio A
    The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.
    Br J Haematol. 2017;178:676-688.
    >> Share

  210. NARITA A, Muramatsu H, Okuno Y, Sekiya Y, et al
    Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
    Br J Haematol. 2017;178:954-958.
    >> Share

  211. PUNARO E, Feltrin KY, Reis F
    Magnetic resonance imaging in acaeruloplasminaemia - a rare differential diagnosis of microcytic anaemia with iron overload.
    Br J Haematol. 2017;178:837.
    >> Share

    August 2017
  212. PARK HS, Park SN, Im K, Kim SM, et al
    Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.
    Br J Haematol. 2017;178:603-615.
    >> Share

  213. GEARD A, Pule GD, Chetcha Chemegni B, Ngo Bitoungui VJ, et al
    Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.
    Br J Haematol. 2017;178:629-639.
    >> Share

  214. MOCKESCH B, Connes P, Charlot K, Skinner S, et al
    Association between oxidative stress and vascular reactivity in children with sickle cell anaemia and sickle haemoglobin C disease.
    Br J Haematol. 2017;178:468-475.
    >> Share

  215. BROWN FC, Collett M, Tremblay CS, Rank G, et al
    Loss of Dynamin 2 GTPase function results in microcytic anaemia.
    Br J Haematol. 2017;178:616-628.
    >> Share

  216. LANCELOT M, White J, Sarnaik S, Hines P, et al
    Low molecular weight heparin inhibits sickle erythrocyte adhesion to VCAM-1 through VLA-4 blockade in a standardized microfluidic flow adhesion assay.
    Br J Haematol. 2017;178:479-481.
    >> Share

  217. ROSE C, Callebaut I, Pascal L, Oudin C, et al
    Lethal ALAS2 mutation in males X-linked sideroblastic anaemia.
    Br J Haematol. 2017;178:648-651.
    >> Share

  218. FISHER AE, Oduro AKY, Adzaku F, Telfer P, et al
    Presentations of sickle cell disease patients to hospital in Ghana: key findings from a preliminary study at Volta Regional Hospital.
    Br J Haematol. 2017;178:489-491.
    >> Share

    July 2017
  219. DUFOUR C
    How I manage patients with Fanconi anaemia.
    Br J Haematol. 2017;178:32-47.
    >> Share

  220. BRUNSON A, Lei A, Rosenberg AS, White RH, et al
    Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
    Br J Haematol. 2017;178:319-326.
    >> Share

  221. CHELI E, Roze J, Garrot T, Tagarist S, et al
    Usefulness of the EMA flow cytometric test in the diagnosis of hereditary spherocytosis post-transfusion.
    Br J Haematol. 2017;178:180.
    >> Share

    June 2017
  222. DUCASSOU S, Leverger G, Fernandes H, Chambost H, et al
    Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
    Br J Haematol. 2017;177:751-758.
    >> Share

  223. COATES TD, Wood JC
    How we manage iron overload in sickle cell patients.
    Br J Haematol. 2017;177:703-716.
    >> Share

  224. MAKUBI A, Roberts DJ
    Investigation and treatment for iron deficiency in heart failure: the unmet need in Lower and Middle Income Countries.
    Br J Haematol. 2017;177:896-904.
    >> Share

  225. TUBMAN VN, Makani J
    Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.
    Br J Haematol. 2017;177:938-946.
    >> Share

  226. JONKER FAM, Te Poel E, Bates I, Boele van Hensbroek M, et al
    Anaemia, iron deficiency and susceptibility to infection in children in sub-Saharan Africa, guideline dilemmas.
    Br J Haematol. 2017;177:878-883.
    >> Share

  227. TLUWAY F, Makani J
    Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
    Br J Haematol. 2017;177:919-929.
    >> Share

  228. MWANGI MN, Prentice AM, Verhoef H
    Safety and benefits of antenatal oral iron supplementation in low-income countries: a review.
    Br J Haematol. 2017;177:884-895.
    >> Share

  229. MAKUBI A, Mmbando BP, Novelli EM, Lwakatare J, et al
    Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.
    Br J Haematol. 2017;177:930-937.
    >> Share

  230. MACKAREL J, Iatan M, Kumar L, Storey L, et al
    In support of upfront stem cell transplantation as first-line therapy for paediatric patients with idiopathic severe aplastic anaemia who lack a sibling donor.
    Br J Haematol. 2017;177:806-808.
    >> Share

    May 2017
  231. KILLICK SB, Bown N, Cavenagh J, Dokal I, et al
    British Committee for Standards in Haematology guidelines for aplastic anemia: Single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 x 109 /L - RESPONSE to Yan et al.
    Br J Haematol. 2017 May 23. doi: 10.1111/bjh.14766.
    >> Share

  232. ALLALI S, Peyrard T, Amiranoff D, Cohen JF, et al
    Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.
    Br J Haematol. 2017;177:641-647.
    >> Share

  233. CYBULSKA A, Meintker L, Ringwald J, Krause SW, et al
    Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure.
    Br J Haematol. 2017;177:612-619.
    >> Share

  234. HOPPE C, Jacob E, Styles L, Kuypers F, et al
    Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.
    Br J Haematol. 2017;177:620-629.
    >> Share

    The genomics of inherited bone marrow failure: from mechanism to the clinic.
    Br J Haematol. 2017;177:526-542.
    >> Share

  236. STANLEY N, Olson TS, Babushok DV
    Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
    Br J Haematol. 2017;177:509-525.
    >> Share

  237. MEUNIER B, Loosveld M, Grados A, Rico A, et al
    Bone marrow erythrophagocytosis and reticulocytopenia in autoimmune haemolytic anaemia.
    Br J Haematol. 2017;177:346.
    >> Share

  238. CHARLOT K, Hierso R, Lemonne N, Romana M, et al
    Changes in autonomic nervous activity during vaso-occlusive crisis in patients with sickle cell anaemia.
    Br J Haematol. 2017;177:484-486.
    >> Share

    April 2017
  239. SINAKOS E, Kountouras D, Koskinas J, Zachou K, et al
    Treatment of chronic hepatitis C with direct-acting antivirals in patients with beta-thalassaemia major and advanced liver disease.
    Br J Haematol. 2017 Apr 25. doi: 10.1111/bjh.14640.
    >> Share

  240. HOSOKAWA K, Kajigaya S, Keyvanfar K, Qiao W, et al
    Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes.
    Br J Haematol. 2017;177:136-141.
    >> Share

  241. BHATIA P, Singh A, Hegde A, Jain R, et al
    Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations.
    Br J Haematol. 2017;177:311-318.
    >> Share

    Clonal dominance of PNH- another piece to the jigsaw.
    Br J Haematol. 2017;177:9-10.
    >> Share

    Microcytic anaemias in childhood and iron-refractory iron deficiency anaemia.
    Br J Haematol. 2017;177:167-168.
    >> Share

  244. HILL QA, Stamps R, Massey E, Grainger JD, et al
    Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.
    Br J Haematol. 2017;177:208-220.
    >> Share

  245. KAWADLER JM, Clark CA, McKinstry RC, Kirkham FJ, et al
    Brain atrophy in paediatric sickle cell anaemia: findings from the silent infarct transfusion (SIT) trial.
    Br J Haematol. 2017;177:151-153.
    >> Share

    March 2017
  246. PUREV E, Tian X, Aue G, Pantin J, et al
    Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.
    Br J Haematol. 2017;176:950-960.
    >> Share

  247. LU J, Lee JH, Huang SY, Qiu L, et al
    Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.
    Br J Haematol. 2017;176:743-749.
    >> Share

  248. HIERSO R, Lemonne N, Villaescusa R, Lalanne-Mistrih ML, et al
    Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
    Br J Haematol. 2017;176:805-813.
    >> Share

  249. TAHER AT
    Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et al.
    Br J Haematol. 2017;176:989-990.
    >> Share

  250. GILL H, Leung GM, Lopes D, Kwong YL, et al
    The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.
    Br J Haematol. 2017;176:991-994.
    >> Share

  251. WU MY, He Y, Yan JM, Li DZ, et al
    A novel selective deletion of the major alpha-globin regulatory element (MCS-R2) causing alpha-thalassaemia.
    Br J Haematol. 2017;176:984-986.
    >> Share

    February 2017
  252. DRASAR E, Fitzpatrick E, Gardner K, Awogbade M, et al
    Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques.
    Br J Haematol. 2017;176:643-650.
    >> Share

  253. PECKER LH, Schaefer BA, Luchtman-Jones L
    Knowledge insufficient: the management of haemoglobin SC disease.
    Br J Haematol. 2017;176:515-526.
    >> Share

  254. MANARA R, Talenti G, Rampazzo P, Ermani M, et al
    Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease.
    Br J Haematol. 2017;176:485-487.
    >> Share

  255. HILL QA, Stamps R, Massey E, Grainger JD, et al
    The diagnosis and management of primary autoimmune haemolytic anaemia.
    Br J Haematol. 2017;176:395-411.
    >> Share

  256. BABUSHOK DV, Stanley N, Xie HM, Huang H, et al
    Clonal Replacement Underlies Spontaneous Remission in Paroxysmal Nocturnal Haemoglobinuria.
    Br J Haematol. 2017;176:487-490.
    >> Share

    January 2017
  257. VITRANO A, Calvaruso G, Lai E, Colletta G, et al
    The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
    Br J Haematol. 2017;176:124-130.
    >> Share

  258. PORTER JB, Cappellini MD, Kattamis A, Viprakasit V, et al
    Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Br J Haematol. 2017;176:288-299.
    >> Share

  259. KOSINSKI PD, Croal PL, Leung J, Williams S, et al
    The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study.
    Br J Haematol. 2017;176:280-287.
    >> Share

  260. DOWLING MM, Quinn CT, Ramaciotti C, Kanter J, et al
    Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.
    Br J Haematol. 2017;176:300-308.
    >> Share

  261. GUIDOTTI F, Piatti G, Marcon A, Cassinerio E, et al
    Pulmonary dysfunction in thalassaemia major: is there any relationship with body iron stores?
    Br J Haematol. 2017;176:309-314.
    >> Share

  262. DOWLING MM, Kirkham FJ
    Stroke in sickle cell anaemia is more than stenosis and thrombosis: the role of anaemia and hyperemia in ischaemia.
    Br J Haematol. 2017;176:151-153.
    >> Share

  263. DAVIS BA, Allard S, Qureshi A, Porter JB, et al
    Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.
    Br J Haematol. 2017;176:179-191.
    >> Share

  264. DAVIS BA, Allard S, Qureshi A, Porter JB, et al
    Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.
    Br J Haematol. 2017;176:192-209.
    >> Share

  265. LA GIOIA A, Bombara M, Fiorini F, Fiorini M, et al
    Pseudo-Chediak-Higashi granules and other unusual cytoplasmic inclusions in refractory anaemia with excess blasts-2.
    Br J Haematol. 2017;176:156.
    >> Share

    June 2016
  266. COUQUE N, Girard D, Ducrocq R, Boizeau P, et al
    Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.
    Br J Haematol. 2016;173:927-37.
    >> Share

  267. THOMAS MR, Robinson S, Scully MA
    How we manage thrombotic microangiopathies in pregnancy.
    Br J Haematol. 2016;173:821-30.
    >> Share

  268. KORDE N, Zhang Y, Loeliger K, Poon A, et al
    Monoclonal gammopathy-associated pure red cell aplasia.
    Br J Haematol. 2016;173:876-83.
    >> Share

    May 2016
  269. ASNANI M, Serjeant G, Royal-Thomas T, Reid M, et al
    Predictors of renal function progression in adults with homozygous sickle cell disease.
    Br J Haematol. 2016;173:461-8.
    >> Share

  270. LEONARDO FC, Brugnerotto AF, Domingos IF, Fertrin KY, et al
    Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Br J Haematol. 2016;173:456-60.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016